Telstar Completes Two Integrated Systems for Lyophilization of Pharmaceutical Products ...

The delivery of two sophisticated systems exemplifies the position of Telstar as an international benchmark in the supply to the biopharmaceutical industry of integrated systems based around proprietary technologies

 

Telstar Completes Two Integrated Systems for Lyophilization of Pharmaceutical Products for R-Pharm and Zambon

Telstar has completed and successfully delivered two integrated systems for lyophilization of aseptic pharmaceutical product in vials, to the Italian company Zambon and the Russian company R-PHARM.  For R-PHARM, Telstar developed a high technology system consisting of a pass-through lyophilizer with a fully automated loading and unloading system.  The loading side operates in a RAB (Restricted Access Barrier) environment while and the unloading side is enclosed within an aseptic isolator which can contain toxic products.  For ZAMBON, the equipment delivered consists of two lyophilizers each with ‘push-in/push-out’ automatic vial loading and unloading systems integrated within a RAB system.  During the low-temperature loading phase the RAB must maintain precise control over temperature and humidity.

 

Telstar, an international leader in the development of high-technology solutions for the pharmaceutical and biotechnology industries, is acknowledged as the only company able to develop and provide integrated systems in the process field for the pharmaceutical and biotechnology industries based on its own sterilisation, lyophilisation, containment and clean air technologies. Telstar invests 3% of its turnover in research, development and innovation of its technologies and equipment.

 

For more information:

 

TELSTAR

Phone: +34 93 736 16 00

Web: www.telstar.eu

Email: marketing@telstar.eu

 

TELSTAR China

Phone: 021-58093731

E-mail: penny.pan@telstar.eu